Ardelyx reported $133.3M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Amgen USD 5.69B 6B Sep/2026
Ardelyx USD 133.3M 6.04M Jun/2026
aTyr Pharma USD 2.55M 126.72K Jun/2026
Corcept Therapeutics USD 225.75M 10.9M Sep/2026
Curis USD 11.52M 2.5M Mar/2026
Sanofi EUR 9.92B 941M Jun/2026
TG Therapeutics USD 174.04M 44.62M Sep/2026
United Therapeutics USD 6.28B 124.3M Sep/2026